Status:
COMPLETED
PET Combined With MRI for Monitoring Inflammatory Activity in Patients With Ulcerative Colitis
Lead Sponsor:
Universität Duisburg-Essen
Collaborating Sponsors:
Crohn's and Colitis Foundation
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Colonoscopy is considered crucial for the diagnosis and quantification of ulcerative colitis (UC). However, there are several drawbacks related to the invasiveness, procedure-related discomfort, risk ...
Eligibility Criteria
Inclusion
- patients with confirmed ulcerative colitis verified by the defining symptoms (rectal bleeding, diarrhea), endoscopy and histopathology
- clinically indicated colonoscopy and 18F-FDG PET as either initial assessment or follow- up examination
- patient age ≥ 18 years
Exclusion
- Patients aged \< 18years
- Patients with MRI contraindications, e.g. presence of cardiac pacemaker, implanted cardioverter-defibrillator, neurostimulation systems or with claustrophobia.
- acute renal failure, severe chronic renal failure (calculated glomerular filtration rate \[GFR\] \< 30 ml/min)
- allergy to i.v. gadolinium based contrast agents
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2018
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT03781284
Start Date
January 1 2016
End Date
October 31 2018
Last Update
December 19 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.